Educational level and use of osteoporosis drugs in elderly men and women: A Swedish nationwide register-based study

Osteoporosis International

Volumn 24, Issue 2, 2013, Pages 433-442

  Wastesson, J W ^a   Ringback Weitoft G ^b   Parker, M G ^a   Johnell, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

Author keywords

Access to health care; Drug therapy; Osteoporosis; Pharmacoepidemiology; Socioeconomic position

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

ADULT; AGED; AGING; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; EDUCATION; FEMALE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; SEX RATIO; SWEDEN;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; EDUCATIONAL STATUS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; REGISTRIES; SEX FACTORS; SWEDEN;

EID: 84873738688     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-012-1945-6     Document Type: Article

References (40)

1. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BEC, Barrett-Connor E, Black D, Bonjour JP (1999) Interim report and recommendations of the World Health Organization task-force for osteoporosis. Osteoporos Int 10:259-264
2. Cooper C, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285-289
3. Borgström F, Sobocki P, Ström O, Jönsson B (2007) The societal burden of osteoporosis in Sweden. Bone 40:1602-1609
4. Borgström F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, Abdon P, Ornstein E, Lunsjö K, Thorngren KG (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17:637-650
5. Kanis J, Burlet N, Cooper C, Delmas P, Reginster JY, Borgstrom F, Rizzoli R (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399-428
6. Kanis J, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK (2002) International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17:1237-1244
7. Kanis J, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12:989-995
8. Brennan S, Pasco J, Urquhart D, Oldenburg B, Hanna F, Wluka A (2009) The association between socioeconomic status and osteoporotic fracture in population-based adults: a systematic review. Osteoporos Int 20:1487-1497
9. Brennan S, Pasco J, Urquhart D, Oldenburg B, Wang Y, Wluka A (2011) Association between socioeconomic status and bone mineral density in adults: a systematic review. Osteoporos Int 22:517-527
10. Ström O, Borgström F, Sen S, Boonen S, Haentjens P, Johnell O, Kanis J (2007) Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial. Osteoporos Int 18:1047-1061
11. SBU (The Swedish Council on Technology Assessment in Health Care) (2003) Osteoporosis - prevention, diagnosis and treatment. A sytematic review. SBU, Göteborg
12. Semerano L, Guillot X, Rossini M, Avice E, Bégué T, Wargon M, Boissier M, Saidenberg-Kermanac'h N (2011) What predicts initiation of osteoporosis treatment after fractures: education organisation or patients' characteristics? Clin Exp Rheumatol 29:89-92
13. Brennan RM, Wactawski-Wende J, Crespo CJ, Dmochowski J (2004) Factors associated with treatment initiation after osteoporosis screening. Am J Epidemiol 160:475-483
14. Unson CG, Fortinsky R, Prestwood K, Reisine S (2005) Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors. J Community Health 30:281-297
15. Vanasse A, Dagenais P, Niyonsenga T, Grégoire JP, Courteau J, Hemiari A (2005) Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec. BMC Musculoskelet Disord 6:33. doi: 10.1186/1471-2474-1186- 1133
16. Johnell K, Fastbom J (2009) Undertreatment of osteoporosis in the oldest old? A nationwide study of over 700,000 older people. Arch Osteoporos 4:17-23
17. Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 162:2217-2222
18. Wettermark B, Hammar N, MichaelFored C, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726-735
19. Naessen T, Parker R, Persson I, Zack M, Adami HO (1989) Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol 130:289-299
20. Statistics Sweden (2004) The Swedish Register of Education. http://www.scb.se/statistik/UF/UF0506/SUN2000English%20version.doc. Accessed 26 Mar 2011.
21. WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway (2011) http://www.whocc.no/. Accessed 21 Jun 2011
22. WHO (2004) ICD-10: International Statistical Classification of Diseases and Related Health Problems: tenth revision, 2nd edn. WHO, Geneva
23. Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in Germany - the BoneEVA Study. Osteoporos Int 18:77-84
24. Haasum Y, Fastbom J, Fratiglioni L, Johnell K (2012) Undertreatment of osteoporosis in persons with dementia? A population-based study. Osteoporos Int 23:1061-1068
25. Johnell K, Weitoft GR, Fastbom J (2009) Sex differences in inappropriate drug use: a register-based study of over 600,000 older people. Ann Pharmacother 43:1233-1238
26. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154:854-864
27. Haider SI, Johnell K, Ringbäck Weitoft G, Thorslund M, Fastbom J (2008) Patient educational level and use of newly marketed drugs: a register-based study of over 600,000 older people. Eur J Clin Pharmacol 64:1215-1222
28. Engel P, Fabre A, Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2011) Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort. Am J Epidemiol 174:12-21
29. Merlo J, Lynch JW, Yang M, Lindström M, Östergren PO, Rasmusen NK, Råstam L (2003) Effect of neighborhood social participation on individual use of hormone replacement therapy and antihypertensive medication: a multilevel analysis. Am J Epidemiol 157:774-783
30. Solomon DH, Brookhart MA, Gandhi TK, Karson A, Gharib S, Orav EJ, Shaykevich S, Licari A, Cabral D, Bates DW (2004) Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med 117:919-924
31. Stocks NP, Ryan P, Elroy H, Allan JA (2004) Statin prescribing in Australia: socioeconomic and sex differences - a cross-sectional study. Med J Aust 180:229-231
32. Johnell K, Ringbäck Weitoft G, Fastbom J (2008) Education and use of dementia drugs: a register-based study of over 600,000 older people. Dement Geriatr Cogn Disord 25:54-59
33. Taylor SE, Repetti RL, Seeman T (1997) Health psychology: what is an unhealthy environment and how does it get under the skin? Annu Rev Psychol 48:411-447
34. Ohlsson H, Lynch K, Merlo J (2010) Is the physician's adherence to prescription guidelines associated with the patient's socio-economic position? An analysis of statin prescription in South Sweden. J Epidemiol Community Health 64:678-683
35. Galobardes B, Lynch J, Smith GD (2007) Measuring socioeconomic position in health research. Br Med Bull 81:21-37
36. Aging Research Center, Karolinska Institutet, Stockholm University (2007) SWEOLD code book 2002 & 2004. Karolinska Institutet, Stockholm
37. Elliot-Gibson V, Bogoch E, Jamal S, Beaton D (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767-778
38. Johnell O, Kanis J, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, Laet CD, Jönsson B (2004) Mortality after osteoporotic fractures. Osteoporos Int 15:38-42
39. Nielsen M, Hansen E, Rasmussen N (2003) Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol 59:677-684
40. Kaufman J (2010) Inequality in provision of medical care in Sweden: a case of social epidemiological hypochondria? J Epidemiol Community Health 64:651-652